ALBT Stock Summary and Trading Ideas (Avalon Globocare Corp. | NASDAQ:ALBT)

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare Corp. trades on the NASDAQ stock market under the symbol ALBT.

As of April 15, 2024, ALBT stock price declined to $0.30 with 37,654 million shares trading.

ALBT has a beta of 1.79, meaning it tends to be more sensitive to market movements. ALBT has a correlation of 0.12 to the broad based SPY ETF.

ALBT has a market cap of $3.35 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ALBT belongs to (by Net Assets): VXF.

ALBT has underperformed the market in the last year with a price return of -85.7% while the SPY ETF gained +25.3%. ALBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.9% and -4.9%, respectively, while the SPY returned +6.2% and -3.6%, respectively.

ALBT support price is $.29 and resistance is $.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALBT stock will trade within this expected range on the day.